Thus, in the thymic lymphoma model, p53 knockdown-mediated cell survival prevented tumors because surviving cells competed with tumor-initiating cells whereas in the sarcoma model p53 knockdown promoted tumors likely by tumor initiation from damaged surviving cells. The gene discussed is TP53; the disease is sarcoma.